|
|
| Eli Lilly to help train doctors on drug-resistant TB - 13, May 2008 |
By Laura MacInnis
GENEVA (Reuters) - U.S. pharmaceutical company Eli Lilly will donate $1 million to train doctors treating tuberculosis (TB), a disease that infects 9 million people every year and kills nearly 2 million.
The interactive online course is meant as a refresher for physicians on the best ways to diagnose, prevent and treat the respiratory infection that spreads through coughs and sneezes and can be especially deadly for people with HIV or AIDS.
"This will allow more physicians around the world to acquire the basic knowledge on standard TB management at a time when there is a resurgence of the epidemic," Eli Lilly said in a joint statement with the World Medical Association.
The emergence and spread of drug-resistant tuberculosis germs have hindered international efforts to stop its spread. According to the World Health Organisation (WHO), 5 percent of tuberculosis cases worldwide cannot be cured with the first-line antibiotics normally prescribed.
Nearly a third of the world's population is infected with the bacterium that causes tuberculosis, although active TB only develops in a fraction of those cases. The dormant bacteria can become active when a patient's immunity levels decrease, for instance if they contract HIV or become pregnant.
Public health officials blame diagnostic and treatment errors on the development of multi-drug resistant strains of tuberculosis, which can be difficult and costly to treat.
Extremely drug-resistant (XDR) tuberculosis that cannot be treated with standard antibiotics has also sprung up as a result of inadequate response to multi-drug resistant strains, such as when the wrong antibiotics are prescribed or when patients do not take the full course of their drugs.
Tuberculosis can also go undetected for extended periods, especially in poor countries where coughing patients can be left in close proximity to those with HIV and other immune-weakening conditions in hospitals and clinics.
(c) 2008 Reuters
|
| Other news from Science category: |
-
NEW YORK (Reuters) - Agribusiness giant Cargill Inc is starting to roll out Truvia, its natural, no-calorie sweetener on Wednesday, and expects the product to be on grocery shelves across the U.S. sometime this fall.
More
-
BARCELONA (Reuters) - The same infrared technology that measures fat content in milk can more accurately predict which embryos have the best chance of resulting in a pregnancy, fertility experts said on Tuesday.
More
-
AREQUIPA, Peru (Reuters) - A magnitude 6.2 earthquake shook southern Peru early on Tuesday, killing at least one person in the Andean country's second-largest city, Arequipa, and damaging scores of homes.
More
-
BARCELONA (Reuters) - Babies born from frozen embryos weigh more, have no greater risk of birth defects and are as healthy or healthier than those conceived using fresh ones, Danish researchers said on Tuesday.
More
-
WASHINGTON (Reuters) - Gels aimed at helping women protect themselves from the AIDS virus may end up helping men as much or more, researchers predicted on Monday.
More
-
AREQUIPA, Peru (Reuters) - A magnitude 6.0 earthquake rattled southern Peru early on Tuesday, startling residents in the Andean country's second-largest city, Arequipa, who ran out of their homes into the streets.
More
-
BANGKOK (Reuters) - Thailand's top court questioned on Tuesday the legality of Bangkok's support for a Cambodian bid to list a disputed Hindu temple as a World Heritage site, giving the opposition another weapon to attack the government.
More
-
MIAMI (Reuters) - Strengthening far more swiftly and vigorously than predicted, Hurricane Bertha became a "major" hurricane in the open Atlantic on Monday, with sustained winds of at least 115 miles per hour (185 kph), U.S. forecasters said.
More
-
WASHINGTON (Reuters) - A new type of vaccine that sneaks into the body and then self-destructs -- all without needles -- may offer a new way to protect against a range of diseases, U.S. researchers reported on Monday.
More
-
LONDON (Reuters) - The British government said on Monday it would not permit badger culling to tackle tuberculosis (TB) in cattle, risking the anger of farmers.
More
|
|
|